- Conditions
- Schizotypal Personality Disorder, SPD
- Interventions
- Cognitive Remediation Therapy, Guanfacine, Placebo
- Behavioral · Drug
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated Feb 27, 2017 · Synced May 22, 2026, 5:47 AM EDT